These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1847638)

  • 21. Specific binding of platelet-activating factor (PAF) by human peripheral blood mononuclear leukocytes.
    Ng DS; Wong K
    Biochem Biophys Res Commun; 1988 Aug; 155(1):311-6. PubMed ID: 2843182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet-activating factor binding to human platelet membranes.
    Valone FH; Ruis NM
    Biotechnol Appl Biochem; 1986 Oct; 8(5):465-70. PubMed ID: 3021183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific binding sites for platelet activating factor in human lung tissues.
    Hwang SB; Lam MH; Shen TY
    Biochem Biophys Res Commun; 1985 Apr; 128(2):972-9. PubMed ID: 2986633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Competitive inhibition of tritium-labeled platelet-activating factor binding to rabbit platelet membranes by amiloride and amiloride analogs.
    Hwang SB
    Biochem Biophys Res Commun; 1989 Aug; 163(1):165-71. PubMed ID: 2549986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of the receptor for platelet-activating factor on human platelets.
    Burgers JA; Akkerman JW
    Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):157-61. PubMed ID: 8385926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Species difference in the specific receptors of platelet activating factor.
    Hwang SB; Lam MH
    Biochem Pharmacol; 1986 Dec; 35(24):4511-8. PubMed ID: 3024653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human platelet activation by PAF: receptor characterization.
    Montesi L; Muzzolini A; Borea PA; Fantozzi R
    Pharmacol Res; 1989; 21 Suppl 1():119-20. PubMed ID: 2561199
    [No Abstract]   [Full Text] [Related]  

  • 28. MK 287: a potent, specific, and orally active receptor antagonist of platelet-activating factor.
    Hwang SB; Lam MH; Szalkowski DM; MacIntyre DE; Bach TJ; Luell S; Meuer R; Sahoo SP; Alberts AW; Chabala JC
    J Lipid Mediat; 1993 Jun; 7(2):115-34. PubMed ID: 8400114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of specific binding sites of 3H-labelled platelet-activating factor ([3H]PAF) and a new antagonist, [3H]SR 27417, on guinea-pig tracheal epithelial cells.
    Herbert JM
    Biochem J; 1992 May; 284 ( Pt 1)(Pt 1):201-6. PubMed ID: 1318021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of 3H-labelled platelet activating factor receptor complex solubilized from rabbit platelet membranes.
    Chau LY; Jii YJ
    Biochim Biophys Acta; 1988 Jun; 970(2):103-12. PubMed ID: 2838093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Occupancy of platelet receptors for platelet-activating factor in asthmatic patients during an allergen-induced bronchoconstrictive reaction.
    Burgers JA; Bruynzeel PL; Mengelers HJ; Kreukniet J; Akkerman JW
    J Lipid Mediat; 1993 Jun; 7(2):135-49. PubMed ID: 8400115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding of platelet-activating factor 1-O-alkyl-2-acetyl-sn-glycero-3-phosphorylcholine to intact platelets and platelet membranes.
    Valone FH
    Methods Enzymol; 1992; 215():224-8. PubMed ID: 1331707
    [No Abstract]   [Full Text] [Related]  

  • 33. 1,4-Dihydropyridines, a new class of platelet-activating factor receptor antagonists: in vitro pharmacologic studies.
    Ortega MP; García MC; Gijón MA; de Casa-Juana MF; Priego JG; Sanchez Crespo M; Sunkel C
    J Pharmacol Exp Ther; 1990 Oct; 255(1):28-33. PubMed ID: 2170624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [3H]52770 RP, a platelet-activating factor receptor antagonist, and tritiated platelet-activating factor label a common specific binding site in human polymorphonuclear leukocytes.
    Marquis O; Robaut C; Cavero I
    J Pharmacol Exp Ther; 1988 Feb; 244(2):709-15. PubMed ID: 2831350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific receptor sites for 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) on rabbit platelet and guinea pig smooth muscle membranes.
    Hwang SB; Lee CS; Cheah MJ; Shen TY
    Biochemistry; 1983 Sep; 22(20):4756-63. PubMed ID: 6313047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of platelet-activating factor binding sites on uterine membranes from pregnant rabbits.
    Kudolo GB; Harper MJ
    Biol Reprod; 1989 Oct; 41(4):587-603. PubMed ID: 2559778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation.
    Ring PC; Seldon PM; Barnes PJ; Giembycz MA
    Mol Pharmacol; 1993 Feb; 43(2):302-12. PubMed ID: 8381515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of the Paf antagonist WEB 2086 and its hetrazepine analogues with human platelets and endothelial cells.
    Korth R; Hirafuji M; Keraly CL; Delautier D; Bidault J; Benveniste J
    Br J Pharmacol; 1989 Oct; 98(2):653-61. PubMed ID: 2555017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ex vivo effects of SR 27417, a novel PAF antagonist, on rabbit platelet aggregation and [3H]-PAF binding.
    Herbert JM; Laplace MC; Maffrand JP
    J Lipid Mediat; 1992 Feb; 5(1):1-12. PubMed ID: 1327264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of PAF receptors on human neutrophils using the specific antagonist, WEB 2086. Correlation between receptor binding and function.
    Dent G; Ukena D; Chanez P; Sybrecht G; Barnes P
    FEBS Lett; 1989 Feb; 244(2):365-8. PubMed ID: 2537761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.